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In troduction
During the past decade, Brazil has been a hotbed of discussion over the ben­
efits and risks of genetically modified organisms (GMOs). While critics ques­
tion the contribution and safety of these organisms and proponents argue for 
their benefits, some scientists struggle to develop good evaluations of their 
potential beneficial and adverse effects. To contribute to the societal delibera­
tion over GMOs, Brazil needs to develop an environmental risk assessment 
based on scientific information and analysis. In this chapter, we consider a 
model for problem formulation and option assessment (PFOA) as a corner­
stone of environmental risk assessment. In a 3-day workshop session the 
authors were introduced to the idea of a PFOA in environmental risk assess­
ment, considered the types of questions and characteristics of the process,
1 The authors and the participants of the PFOA discussion group at the workshop 
acknowledge Dr Maria José A. Sampaio of the Embrapa Secretariat for Intellectual 
Property Rights and Dr Ana Lúcia Assad of the Ministry of Science and Technology 
at the time of the workshop, for their contribution of ideas during the workshop.
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and made consensus recommendations about the value of a PFOA. Of partic­
ular interest in the Brazilian case study, the authors support findings from pre­
vious publications (Nelson et al., 2004), discuss how the PFOA might fit 
within existing Brazilian laws and regulations, and evaluate the staging of the 
PFOA as it blends with other components of a GM O’s environmental risk 
assessment. The authors of this chapter have focused on science and environ­
mental issues but recognize that others will need to be involved to understand 
how legal, ethical, social and economic issues can be included in risk assess­
ment. The next step for a Brazilian team is to design the process for the 
PFOA based on a broader period of consultation and implement the PFOA 
within environmental risk assessment.
Since the global debate about the possible benefits and risks of GMOs has 
largely been framed by stakeholders from the developed world, governments 
in developing countries have found themselves in a dilemma. In some coun­
tries, a general apathy emerged and slowed adoption of GMO technology in 
agricultural systems. In many countries, political arenas provided the only 
avenue for debate, making it increasingly difficult to design effective and 
responsible GMO regulation that strikes a balance between safety and com­
petitiveness, taking into account each country’s unique context of society and 
ecosystems.
Certainly, transgenesis is a complex topic that embodies difficult techni­
cal, social and economic issues played out against a backdrop of human 
hunger, economic marginalization and environmental degradation (Traynor 
et al., 2002). In Brazil, transgenesis has not enjoyed the same acceptance by 
consumers as it has in the USA or Argentina, where it is viewed by some sec­
tors of society as a major tool to aid in the development of agribusiness. 
Scientific, legal, ethical, environmental, social and economic issues are hotly 
debated. Concerns are also associated with complicated issues such as 
labelling, market barriers and global commerce. Media information sources 
are full of contradicting opinions from scientists, government authorities and 
citizen groups. Within this context, it is very difficult for Brazilian consumers 
to understand or trust any given comment or decision (Nutti et al., 2004, 
among others).
As a rule, the development of any novel technology emphasizes market 
issues. The current Brazilian situation indicates that the importance of safety 
issues associated with transgenesis will influence the path of development of 
transgenic crops; this path will follow a different route than technologies in 
other industrial sectors. Development of agricultural transgenic products will 
require consideration of other aspects, such as precise information about this 
new technology available to the consumer, with trustworthy scientific analysis 
as a reference point in the process.
Although experience has been acquired with products developed and com­
mercialized in other countries, safety protocols should be developed and/or 
adapted to local conditions. In some countries there are limited monitoring and 
postharvest results (Department of Agriculture, Western Australia, 2004), but 
in most countries we lack this information. To ensure environmental safety, it 
will be necessary for each country to establish its own protocols, since results
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may differ from those already obtained in other regions of the world. Food and 
Agriculture Organization (FAO) officials emphasize this point in the following 
statement:
FAO supports a science-based evaluation system that would objectively 
determine the benefits and risks of each individual GMO. This calls for 
a cautious case-by-case approach to address legitimate concerns for the 
biosafety of each product or process prior to its release. The possible 
effects on biodiversity, the environment and food safety need to be 
evaluated, and the extent to which the benefits of the product or 
process outweigh its risks assessed. The evaluation process should also 
take into consideration experience gained by national regulatory 
authorities in clearing such products. Careful monitoring of the postre­
lease effects of these products and processes is also essential to ensure 
their continued safety to human beings, animals and the environment.2 
(2004, p. 225)
The report goes on to recognize that there are few ecological studies in tropi­
cal areas and that more research will be necessary to address ecological risks in 
these areas. Brazil should review existing studies, using the findings when 
appropriate and establish its own robust research programme when necessary.
In 2003, a governmental decision unified the positions of the agencies 
regarding the necessity of health and environmental risk assessment analysis 
prior to large-scale GMO use. The prospect of increasing profits in major agri- 
cultural-commodity markets has prompted multinational companies to invest 
heavily in the acquisition of seed companies located in large Latin American 
countries such as Brazil. Consequently, major genes of economic importance 
that were used during the first wave of transgenic products in the USA and 
Europe are being transferred to Brazilian tropical varieties and are being 
experimentally tested in the country in accordance with the biosafety law 
passed in 1995 (Fontes, 2003). In June 2003, only one herbicide-tolerant 
(HT) soybean event had been approved for two planting seasons (2002/03 
and 2003/04); approval was granted by the Brazilian National Congress 
because the decision-making authority of the National Technical Biosafety 
Commission had been challenged judicially. This Congressional approval was 
a temporary emergency measure to address the problems originating from 
illegal plantings of HT soybeans while the judicial challenge was pending.3
The focus of this chapter is motivated by two important concerns: (i) 
concern that premature release of GMO varieties will preclude critical steps
2 There is an active debate about whether anything can be or should be considered 
‘objective’. Stakeholder values are specifically not ‘objective’ and yet they are impor­
tant components of the societal evaluation of risk. The authors have a worldview that 
science has something valuable to contribute to societal discussions, and to risk 
assessment in particular. The PFOA process is designed to include the broader soci­
etal discussion but enhance the way science informs this discussion.
3 The production and marketing of HT soybean has been authorized in the new 
biosafety law, as well as the planting of saved seed in the season 2004-2005. See 
Background on Brazil Biosafety Legislation for GM crops (this chapter).
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in environmental risk assessment; and (ii) the desire of Brazilian scientists 
and regulators for a carefully designed ‘best science model' for the wise 
management of transgenic products. The challenge for chapter authors was 
to recognize and understand the conflicted nature of the GMO discussion in 
Brazilian society, while finding a common ground from which it is possible 
to move forward. In the PFOA model, multi-stakeholder participants have to 
formulate the problem that may be addressed by the GMO, as well as under­
stand its scale and priority for society. Once this is accomplished the group 
has to compare possible options for solving the problem and evaluate the 
relative merit of the GMOs.
In Brazil, the science to assess GMOs is just beginning to be established as 
a foundation for review. As an example of one argument in the debate, 
Contini et al. (2003) used a simulation model to assess the potential econom­
ic benefits to the Brazilian economy resulting from unrestricted commercial 
approval of HT soybeans and other key crops. Model results indicated that 
economic benefits of legally adopting glyphosate-tolerant soybeans may be 
very high, and may also be significant for other transgenic crops such as 
maize and cotton. Contini et al. (2003) concluded that even though the coun­
try is fully capable of developing the necessary food-, feed- and environmen- 
tal-safety tests, political and ideological reasons have prevented any legal 
commercialization of transgenic crops. Conversely, other scholars (Pelaez 
et al., 2004) concluded that transgenic HT soybeans are not more profitable 
than conventional soybeans. Overall, there are still insufficient scientific data 
to reach a common conclusion.
Some stakeholders believe government agencies in Brazil should have 
taken the lead to clarify legal requirements for research and commercial 
release of GMOs. In media reports, journalists highlight the concern that it 
was difficult for Brazilian researchers involved with biotechnology to accept 
the state of chaos and confusion created by the disputes between pro- and 
anti-GMO campaigners, while the illegal use of GM seeds emerged 
(Bonalume Neto, 2003). Clarifying regulations is the main objective of the 
new biosafety law.
While the societal discussion continues, farmers are making decisions 
about their production systems, and often pursue technologies that give them 
the best agricultural and economic returns. However, some stakeholders 
argue that a balance between environmental and human health concerns and 
competitive agricultural practices, including use of transgenic crops with high 
economic return, must soon be reached to avoid the growth of illegal planting 
areas (not only as occurred for glyphosate-tolerant soybeans). Another alter­
native small farmers are increasingly adopting is the agroecological 
approach,4 in which transgenic varieties are not part of the system. 
Compared with the traditional, conventional agricultural system or with sys­
tems that use transgenic varieties, the agroecological one can be more envi-
4 In this case, the agroecological approach refers to a philosophy and system of 
farming that uses ecological principles, such as natural enemies, to guide decision 
making in production for a more sustainable system.
Consideration of PFOA 71
ronmentally safe, because it strives to reduce the use of pesticides, and other 
negative environmental impacts such as soil erosion and nutrient runoff 
(Altieri, 2000). Recently, the 7th Conference of the Parties of Convention on 
Biological Diversity, held in Kuala Lumpur, 2004, approved a programme of 
work on the ecosystem approach to be adopted by parties across the world 
(CBD, 2004).
Despite the urgency of the scientific assessment to support safe agricul­
tural technology, scientists want to carefully design appropriate research pro­
tocols and regulatory processes that will be received with confidence by 
decision makers and the general public. In a field with tremendous uncertain­
ty, testing regimes can serve as a framework for improved understanding and 
analysis for public discussion. But how can each country come to its own 
agreement on an acceptable risk-assessment strategy? Critics argue that there 
has already been too much done with risk assessment. Brody (2002) argues 
that the money invested around the world in compliance and enforcement of 
biosafety rules, regulations and laws might be better spent in ways that would 
save many more lives. Others think we have only begun to understand what 
will be necessary in risk assessment. Some stakeholders argue for internation­
al standards in environmental protocols that would, at a minimum, harmonize 
requirements for similar cases and lead to better understanding of risk assess­
ment, communication and management of GMOs. Such standards and assess­
ment would differ dramatically from the more commonly known 
environmental-impact analysis done before construction of roads, dams or 
buildings.
The GMO Guidelines Project entered the Brazilian discussion with a 
workshop in June 2003, designed to encourage discussion among interna­
tional and Brazilian scientists and regulators.5 The purpose of this discussion 
was to develop recommendations for environmental risk assessment protocols 
and processes that would serve as the basis for public deliberation and sound 
national decision making. This chapter represents consensus of the authors 
based on the workshop and subsequent discussions.
PFO A M ethod6
PFOA is one cornerstone of GMO’s environmental risk assessment. Countries 
must create a responsive system to facilitate socially acceptable choices (Stern 
and Fineberg, 1996). At its core, the discussion focuses on the critical societal 
need7 that will be addressed by the GMOs, i.e. which needs will be satisfied 
and at what risk? Societal needs and risks require societal reflection. Countries
5 For more on the scope, purpose and sponsorship of the GMO Guidelines Project, 
see the preface or visit the project website: http://www.gmo-guidelines.info
6 The PFOA method section has been modified from the original methods text in 
Nelson et at. (2004).
7 Societal benefits are distinct from societal needs in that they could be any positive 
contribution to the broader society, such as increased income or more choice, and 
based on different values.
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accept the possibility that something negative might happen with most major 
policy decisions but they never do so lightly. A deliberative process with multi­
stakeholder participation allows members of society to participate in the eval­
uation of critical needs and risks. A cross section of society - farmers, 
consumer groups, industry, environmental representatives, policy makers, 
etc. - must have a vehicle to express their concerns and evaluate the future 
alternatives for addressing basic needs. Finally, this deliberative process8 will 
become increasingly important for resource-scarce nations if public invest­
ment is involved, because a comparative reflection by a cross section of socie­
ty may be beneficial in prioritizing and targeting resources.
Given present uncertainties surrounding GMOs and regular reports of 
new discoveries about GMOs, the system to conduct a deliberative discussion 
should be flexible and able to respond to a society’s core values, concerns and 
needs. At the same time, the discussion is best served if it is driven by sound, 
scientifically guided assessment and review (Gibbons, 1999; CBD, 2000; 
NRC, 2002). A robust environmental risk assessment clearly delineates when 
scientific knowledge, information and analysis can effectively respond to key 
questions and when it cannot.
In most natural-resource arenas, practitioners and scholars are imple­
menting and evaluating diverse options for societal discussion about critical 
issues (O’Brien, 2000; Wondolleck and Yaffee, 2000). Specific contributions 
within the biosafety arena have detailed potential approaches to multi-stake­
holder dialogues and participation (Skorupinski, 2001; McLean et al., 2002; 
Glover et al., 2003, Kapuscinski et al., 2003) and the evaluation of their key 
attributes (Irwin, 2001) at international and national scales. Societal discussion 
is advocated in setting priorities and strategies for agricultural research and 
development, in formulation of national biosafety frameworks and in environ­
mental risk assessment of specific biotechnologies. A PFOA is applicable to all 
of these contexts, and can be employed in an iterative fashion to incorporate 
feedback from changing societal values and the scientific state of the art. In 
the Brazilian Bacillus thuringiensis (Bt) cotton case study presented in this 
chapter, PFOA creates the context for societal dialogue concerning the poten­
tial use of a proposed technology based on a transgenic organism such as Bt 
cotton. It is public deliberation about the transgenic organism that provides a 
rational, science-driven planning process by which multiple stakeholders can 
assess their needs, evaluate risks related to multiple future options, and make 
recommendations to decision makers about policies to reduce societal risks 
and enhance the benefits provided by various options.
Certainly the requirements set forth to accomplish a PFOA is a complex 
process - but this should not be considered as a possible argument against its 
use. Most important societal decisions are complex, messy and controversial, 
and because they are complex, messy and controversial we should work to 
improve them with transparent, systematic and scientifically based discussion. 
By doing so, the decision-making process gains social legitimacy and society
8 In this case a deliberative process refers to one based on an ‘organized or careful 
discussion and debate’.
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gains greater confidence in the decisions taken. A PFOA can be used to pro­
vide such a discussion, and may play a significant role in environmental risk 
assessment.
R elation  of PFO A  to  en v iro n m en ta l risk assessm en t
Practitioners and scholars have tested numerous techniques that serve as a 
methodological foundation for the PFOA in environmental risk assessment 
(Grimble and Wellard, 1997; Kessler and Van Dorp, 1998; Schmoldt and 
Peterson, 1998; Biggs and Matsaert, 1999; Loevinsohn et at., 2002, to 
name a few). Two crucial steps in risk assessment are addressed by many of 
these techniques, and this PFOA model is designed specifically to address 
them. The first critical step in risk assessment is problem identification (NRC, 
1983, 1996). What is the scope of the problem, how is it defined? Problem 
identification frames the entire risk assessment. A second critical step is the 
identification of potential alternative solutions to the problem (NRC, 1983, 
1996). The proposed action - in this case, the use of Bt cotton in Brazil - is 
never the only possible way to address the problem. Risk assessment depends 
entirely on an appropriate specification of alternatives (including taking no 
action and doing nothing), so that comparative risk can be assessed, and 
appropriate controls for risk assessment science can be defined and used (see 
other chapters in this volume).
This PFOA model is comprised of specific brainstorming discussion and 
analytical components (Table 3.1). First, formulating the problem serves as the 
core foundation. The problem is defined as an unmet need that requires 
change (Goldstein, 1993). Basic human needs are most commonly identified 
as food, shelter and safety. Other human interests are stakeholder-specific such 
as enhanced economic opportunity, positive social interactions or cultural rich­
ness. For example, as a minimum foundation for well-being, individuals have a 
basic need for a certain amount of calories per day or the security that their 
children will continue to live healthy lives. Once the needs for food, shelter and 
safety are met, individuals can expand their interests to include numerous 
options for well-being. These interests will differ from one individual to anoth­
er and from one group to another.
After a problem is identified, the PFOA model requires a comparative 
approach to risk assessment. The participants clarify the relative importance of 
this problem as compared to other problems or issues. Once the group agrees 
the problem is sufficiently important to merit an analysis, the range of future 
alternatives for solving the problem are compared in relation to their attributes, 
potential ability to address the problem, changes required to implement the 
option and potential adverse effects. The PFOA is planning for alternative 
futures, not for the current conditions against one option; rather, the PFOA 
makes a comparative assessment of alternative futures. After a complete analy­
sis by a multi-stakeholder group, a recommendation is made to decision mak­
ers to continue research and development (in some cases risk-assessment 
research) with the technology or to halt the development of the technology.
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Table 3.1. Problem formulation and options assessment process.
Initiating proposal
A. Proposal to use GMOs
Any PFOA for transgenic organisms will be initiated by the request or suggestion that a 
particular GMO would be a beneficial alternative to the way things are currently being done 
in a particular cropping system.
B. Decision by regulatory body
Is there merit to moving forward to evaluate the GMO as a possible option or is the initiating 
proposal premature? Yes/No
PFOA process: questions to be answered by all representatives and shared in the 
deliberative process
Step 1: Problem formulation
Formulation of problem Basic human needs Interests
An unmet need that Food, shelter, safety A stakeholder group’s
requires change values, goals and
perspectives
A. Whose problem is it? Whose problem should it be?
1. What needs of the people are not being met by the present situation?
2. What aspects of the present situation must be changed to meet the needs?
Step 2: Prioritization and scale
A. Is this problem a core problem for the people identified?
1. Do the people recognize the problem as important to their lives?
2. What are the potentially competing needs of these people?
3. How do the identified needs rank in importance to these other competing needs?
B. How extensive is the problem?
1. How many people are affected?
2. In what part of the country are these people located?
3. How large an area is affected by the problem?
4. How severe is the problem (local intensity)?
Step 3: Problem statement
Shared understanding of the unmet need and its relative importance for a particular group of 
people.
Step 4: Recommendation by regulatory body
Do we move forward to identify options and conduct and options assessment?
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Tatle 3.1. Problem formulation and options assessment process -  cont’d.
Opion identification and assessment





Effect on the system







Step 5: Option identification
Branstorm possible future alternatives to solve the identified problem; transgenic organisms 
wodd be one option. This step can be completed by the multiple stakeholder group for the 
initiil identification of options. The multi-stakeholder group can do steps 6-8 or a technical 
corrmittee can develop a report that covers steps 6-8 and the multi-stakeholder group can 
use the document to begin their evaluation of options and modify the assessment.
Stef 6: Assessment of the options in relation to the problem
Assessing capability of potential solution to solve problem.
1. V'hat are the characteristics of the ‘technology’ option i.e. transgene, intercropping 
system?
2. Vhat is the range of crop-production systems and what is the geographical region the 
ojtion is likely to be used in or have an effect on?
3. V\hat is the efficacy of the ‘technology’ on the target?
4. V\hat are the costs of the technology within the crop-production system?
5. V\hat barriers to use exist? For instance, is the seed-distribution system in place; can the 
potential solution be integrated into present production; can the farmers afford the poten­
tial solution?
6. H)w might the use of the option change cropping practices, such as tillage systems or 
pesticide use (including impacts on non-target pests)? What useful practices are 
renforced by the potential?
7. Wiat information is needed to show that the changes are likely to occur? Baseline data 
associated with the diversity of present practices should be used if it is available.
8. How will anticipated changes in agricultural practices affect the needs identified in 
stops 1 and 2?
Step 7: Changes required and anticipated for a specific option
1. Wiat changes in farm management practices might contribute to the solution?
2. Wiat changes in the local community might contribute to the solution?
3. Wiat changes in government support for farmers might contribute to the solution?
4. Wiat changes in the structure of agricultural production might contribute to the solution?
5. Wiat other changes would likely be needed to facilitate widespread use of this option?
Continued
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Table 3.1. Problem formulation and options assessment process -  cont’d.
Step 8: Adverse effects
Potential adverse consequences from this option. Potential beneficial effects can be consid­
ered ‘negative’ adverse effects.
1. How might the potential solution affect the structure of agriculture or agricultural infra­
structure?
2. How might the potential solution reinforce poor agricultural practices or disrupt useful 
practices'?
3. What are the potential adverse effects of these changes internally and externally to the 
production system?
4. How will its use affect other nearby crop-production systems and non-agricultural environ­
ments (can its use be restricted to a particular cropping system or geographical region)?
5. Are any of these changes difficult to reverse, once they occur?
Step 9: Recommendation
The multiple stakeholder group should present their problem formulation and option assess­
ment to the appropriate decision-making body.
A science-driven PFOA must be a deliberative process (Forester, 1999) 
designed to provide for social reflection and discussion about transgenic 
organisms. A sound deliberative process is transparent, equitable, legitimate 
and data-driven when possible (Susskind et at., 2000). Transparency allows 
for open communication of information between all parties and easily accessi­
ble reporting of decisions to the public (Hemmati, 2002). Providing an equi­
table PFOA process means that information from the broadest spectrum of 
society must be included with all stakeholders having the possibility to con­
tribute. Civil society must perceive that there are sufficient avenues for input 
and consideration of diverse viewpoints and concerns. When transparency 
and equitable input are central to the process, the PFOA gains legitimacy in 
the public eye. This public legitimacy must be matched by traditional legitima­
cy or sanctioning by a formal political body that embeds the deliberative 
process. The deliberative process can be tied to a regulatory authority or leg­
islative authority, but it must provide a means by which results from the PFOA 
inform government decision-making and action. Finally, the foundation of 
PFOA is a science-driven inquiry - in both environmental and social sciences. 
Questions are answered with data, impacts are assessed with valid indicators, 
and the limits of our understanding are clearly delineated by a research agen­
da or procedures for taking uncertainty into account.
Each country will need to develop a country-specific deliberative process 
that fits the particular structure and authority of the relevant decision-making 
bodies and implementing agencies. For many political systems in the world, 
the legitimating authority exists to incorporate PFOA in a legislative or regula­
tory context, but there are debates about necessary modifications of policies
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and regulation for transgenic organisms (Munson, 1993; Miller, 1994; 
Hallerman and Kapuscinski, 1995; Sagar et al., 2000; NRC, 2002). For 
some legislative or regulatory situations, a PFOA can be incorporated into a 
public consultative process that is authorized by regulation or it may be added 
as an alternative process supported by civic society that informs the debate in 
traditional decision-making bodies.
The following sections describe the regulatory background in Brazil, in 
order to facilitate the consideration of how a PFOA would best fit in the exist­
ing system in Brazil, and document a trial run of the PFOA model proposed 
for this risk assessment approach. It is not a PFOA for Bt cotton. It is an eval­
uation by the authors of the concepts and protocols for this PFOA model.
Background on B razilian B iosafety Legislation for GM Crops
In an effort to assure society that care and precaution will be taken to warrant 
both environmental and human health safety of all food/feed produced from 
GMOs, Brazil has been working, for nearly a decade, to enact regulatory leg­
islation. A brief report of the accomplishments so far is as follows.
P ast B razilian  b io s a fe ty  le g is la tio n  and th e  p res s u re  fo r  ch an g e
Law no. 8974 of 1995: The superceded Brazilian Biosafety Law for GM 
crops involved regulatory agencies under three ministries. Each agency grant­
ed both special temporary testing permits and final licensing for commercial 
products according to their own rules and protocols. In addition, in the case of 
plants containing biopesticide traits, specific pesticide-control legislation also 
applied (Law no. 7802, of 1989),9 and Resolution 305 (June 2002) of the 
National Environmental Council (CONAMA) stated that GMO research 
and development are subject to the requirement of environmental impact 
studies - a preliminary step to any polluting activity.
The National Technical Committee for Biosafety (CTNBio) under the 
Ministry of Science and Technology, was given responsibility for assessment of 
health and environmental risks posed by GMOs. However, CTNBio’s legal 
capacity to perform as stated in the Provisional Measure (PM)10 in 2001 has 
been repeatedly challenged judicially (the case in point was a CTNBio decision 
concerning glyphosate-tolerant soybeans). This challenge ended in August 
2004, with two judges voting to uphold and one voting to deny the CTNBio 
legal authority.
9 Pesticide Law no. 802/1989 and Decree no. 4.074/2002 available at http://www. 
planalto.gov.br
10 A Provisional Law Measure is a legal entity used by government when it needs 
any given law to go into force before it is submitted to the congress for approval. It is 
valid for 90 days and has to be voted and approved.
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Difficulties of the regulatory agencies in defining their own rules and pro­
tocols, coupled with the legal entanglements concerning CTNBio’s mandate, 
resulted in a nearly complete halt of GMO research projects of plants produc­
ing biopesticide products from 2001 up to 2003. Particularly affected was 
research on virus-resistant GM plants. Confronted with this research crisis, 
the agencies sped up their protocols, and in September 2003, Brazilian 
Agricultural Research Corporation (Embrapa) was licensed to plant a GM 
papaya field trial in the north-eastern state of Bahia. In 2004, Embrapa was 
licensed to field test GM beans and GM potatoes. In all three cases, the trans­
gene was designed for virus resistance. After these, private companies 
obtained licences to conduct similar research.
Resolution 305 (June 2002) of the National Environmental Council 
(CONAMA)11 stated that GMO research and development are subject to the 
requirement of environmental impact studies - a preliminary step to any pol­
luting activity.
Labelling: Decree no. 4680 (April 2003) guarantees the right of infor­
mation - as established in the Brazilian Consumers Defence Law (Law no. 
8.078 of 1990) - compelling the labelling of every food that contains more 
than 1% of a GM ingredient. It also determines that animals that have been 
fed with transgenic grains, as well as the products prepared with the animals’ 
meat, milk and eggs must be labelled. Practical difficulties in Brazil will make 
this labelling statute difficult to implement effectively.
T h e  n e w  b io s a fe ty  law
Dissatisfaction with the ambiguities in the present legislation and the conse­
quent difficulties to research led the government to submit a new bill to 
Congress, in November 2003, which was passed and signed by the president 
on March 24 2005.12
The new law covers licensing for laboratory, greenhouse, and field experi­
ments, and applications in the areas of agriculture, environment and health. It 
assigns authority to CTNBio13 for issuing technical opinions, case-by-case, on 
both research-related activities and the commercial use of GMOs and their by­
products. The CTNBio opinion is forwarded to the registration and inspection 
agencies - SDA (Plant Protection Secretariat, Ministry of Agriculture), IBAMA 
(Brazilian Institute for the Environment, Ministry of Environment), and ANVISA 
(National Agency of Sanitary Control, Ministry of Health). The agencies are 
responsible for inspection and monitoring in their respective areas. They are
11 Available at: http://www.mma.gov.br/port/conama/index.cfm
12 An English translation of the law is available at: http://www.ctnbio.gor.br/index. 
php?action=/content/view&cod_objeto=1296
13 The new CTNBio will be composed of 27 experts: 12 scientific experts in the 
areas of human health, animal health, plant health and environment, nine Ministry 
representatives, including the three regulatory Ministries, and six other experts cho­
sen by specific ministries for specific areas of expertise.
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bound to CTNBio’s opinion, and in the case of research, CTNBio is expressly 
given final authority. However, whenever there is dissension regarding 
CTNBio’s technical opinion on commercial use of a GMO, the registration and 
inspection agencies can appeal. The final decision on commercialization then 
lies with the new National Biosafety Committee (CNBS), made up of 11 minis­
ters and subject to the Office of the President of the Republic. The CNBS can 
also, upon CTNBio’s request, analyse the socio-economic convenience and 
opportunities and national interest entailed in the requests for commercial use.
At the time of writing, the rules governing the operation of the expanded 
CTNBio and the CNBS are still being discussed and it is unclear how the law 
will function. One recent decision taken by the old CTNBio related to impor­
tation of Bt maize varieties for animal feed14 has been suspended by the 
CNBS, allowing just the three events analysed by CTNBio (gen CrylAb, 
CrylAc and Cry9C, for insect resistance; gen pat and bar, for glyphosinate 
herbicide tolerance; and gen mEPSPS, for glyphosate herbicide tolerance) to 
be imported.15 Two other decisions of the old CTNBio that required analysis by 
CNBS have not yet been delivered: on commercialization of Bollgard Bt cot­
ton and transgene contamination limit in cotton seed.16
P ro v is io n a l m ea su re s
The increase in illegal planting of GM soybean and the delays in the judicial 
decision prompted the government to issue two PMs: PM 113 and PM 131. 
The first one was issued specifically to legalize marketing of GM soybean har­
vested in the early months of 2003, while the second was to legalize, for only 
1 year, the 2003/04 planting and marketing of transgenic soybean seeds 
retained from the previous harvest. The production and marketing of HT soy­
bean has been authorized in the new biosafety law, as well as the planting of 
saved seed in the season 2004/05. Since then, various HT soybean varieties 
have been brought onto the market in Brazil.
A c o n s e n s u s  p ro p o sa l
At another scale, the international forecast for the implementation of the 
Cartagena Protocol on Biosafety, which came into force in September 2003, 
but really gained momentum after the first meeting of the parties that took 
place in Malaysia, February 2004, implies that all signers will need to have 
risk-assessment regulations in place. Brazil became a party to the Cartagena 
Protocol in February 2004 and has not yet developed all the procedures 
required for export and import of GM products.
14 Available at: http://www.ctnbio.gov.br/index.php?action=/content/view&cod_objeto= 
1305 (English version) or http://www/ctnbio.gov.br/index.php?action=/content/view& 
cod_objeto=1299 (complete, Portuguese version)
15 Source: Technical note from Dr Monica Amancio, lawyer.
16 Source: http://www.prdf.mpf.gov.br
80 D.M.F. Capalbo et al.
Bt co tto n  in th e  B razil re g u la to ry  sys tem
Regarding government decisions specific to the present case study, Bt cotton 
varieties owned by multinational companies were granted approval from the 
CTNBio for field trials beginning in 1997, in various regions of Brazil. These 
varieties produce the proteins CrylAb, CrylAc and Vip3A, and one variety 
contains both CrylAb and CrylAc. In 2000, a court injunction suspended 
these tests until they were granted approval by other Brazilian regulatory agen­
cies. During the years 2001-2005, the companies did not receive approval for 
new field trials. On March 18 2005, the old CTNBio made a recommendation 
to commercialize Bt cotton containing Bollgard event 531. Their decision has 
been suspended by the CNBS and is being examined.
Test Run for the PFO A M odel in the Brazil Case Study for 
Bt Cotton
The authors evaluated the PFOA model by discussing its purpose within an 
environmental risk assessment, testing a few questions from each step in the 
model to experience the type of discussion that might result from a multi­
stakeholder exchange (Table 3.1), and deliberating over how a PFOA would 
best fit in the Brazilian regulatory system. The authors then summarized their 
findings about the PFOA content and process within the context of Brazil’s 
deliberation over Bt cotton.
After discussing the questions in steps 1 and 2 (Table 3.1), the authors 
came to a consensus on the following problem statement for cotton pest 
problems.
P ro b lem  s ta te m e n t
During periods of high infestation, Lepidopteran pests cause yield reduc­
tions in cotton, increasing the number of insecticide applications and con­
sequently increasing the cost of cotton production, possibly affecting the 
health of farmers and people who are inuolued with the crop, also causing 
environmental pollution in the soil and water systems. Reduced stability 
of yield makes planning more difficult and risky.
In the North-east, for small-scale farmers, the boll weevil damages cot­
ton during the rainy season (March-May). Lepidopteran pests are not a 
major problem.
In the Midwest and Meridian regions, Lepidopteran pests are a mod­
erate to major problem.
Continuing the test run of the PFOA model, we conducted a brainstorm­
ing session about possible options for addressing the problem. The options 
included Bt cotton, insecticide applications, biological control with 
Trichogramma wasps, integrated pest management (IPM) packages and 
organic packages. We selected Bt cotton, biological control (wasps) and
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insecticide applications as options used to evaluate questions in steps 6-8. 
Overall, our conversation jumped around a great deal, but participants devel­
oped a sense of the type of discussion produced by the questions and where 
the difficulties would emerge.
E v a lu a tio n  o f a B razil P FO A
After reviewing the PFOA model and discussing the Kenya case study, the 
Brazilian authors agreed with their Kenyan counterparts on five key findings 
(Nelson et al., 2004) and refined them in several aspects.
Finding #1: PFOA is a good idea for any agricultural technology but 
critical for GMOs. It should be done taking into consideration a precau­
tionary approach on a case-by-case basis.
Finding #2: PFOA proved to be particularly useful for encouraging 
constructive dialogue and potential agreements.
Finding #3: For a successful PFOA, a nation should have in place a 
regulatory framework that would allow for the reduction of uncertainty 
about GMOs. Consideration of the PFOA could help to initiate discussions 
about possible regulatory options.
Finding #4: The discussion of a case study provides applied insights 
about key issues and consensus building.
Finding #5: Additional questions will strengthen the PFOA: what loss 
has occurred as a result of the problem in productivity as well as environ­
mental, social and economic aspects? How will the technology’s use affect 
the environment? How will use of the technology affect the conservation 
of genetic variability of the species and other related biodiversity?
We find there is a demand for a new way to host societal discussions, just as 
scholars have documented the need for creative approaches to critical natural 
resource-problem solving and risk assessment in other countries (O’Brien, 
2000; Wondolleck and Yaffee, 2000). The use of a PFOA process in environ­
mental risk assessment for GMOs provides a framing of the risk-assessment 
stages, allowing diverse stakeholders in the PFOA to propose issues that need 
to be evaluated in the risk-assessment stages, as well as serve as a multi-stake- 
holder discussion that can use the scientific results from the assessment to 
inform their evaluation of the options. The uncertainty associated with GMOs 
as an alternative make a PFOA process critical, so multiple stakeholders can 
contribute their views and science is used to inform the discussion.
Due to the nature of the GMO discussion, and the absence of sufficient sci­
entific biosafety data in Brazil and monitoring data after release of new products 
or techniques in other countries, several authors believe it would be necessary to 
take a precautionary approach for each GMO technology. A precautionary 
approach, as represented in European regulation, balances between the need to 
take action and scientific uncertainty (Skorupinski, 2004), with the philosophy 
that if there is a ‘reasonable assumption of possible harm’ then the government 
should take measures for protection (CEC, 2000). Certainly, Brazil will need to 
develop its own understanding of the precautionary approach.
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In particular, the options assessment would have to include more specific 
questions about environmental risks and a well-documented analysis of the 
crop losses a new technology would address. The adoption of a new technol­
ogy might cause changes in environmental and societal aspects, which are not 
necessarily explicit. Purely economic questions should not obscure other 
aspects related to the problem. We must also consider the entire ecosystem 
involved, as well as the consequences for human health and well-being. For 
example, in the past some newly introduced technologies in a production sys­
tem (e.g. chlorofluorocarbons (CFCs), pesticides) largely served to produce 
economic gains for multinational companies, but without regard for other 
consequences that could alter the components of the water-soil-atmosphere 
system and its relationship with living organisms.
The authors (a diverse group of ministry officials) believe a PFOA model 
would be useful for constructive dialogues, new insights and the consensus 
building necessary for possible agreements in Brazil, a finding supported by 
studies of multi-stakeholder dialogues in other countries (Irwin, 2001; McLean 
et al., 2002; Glover et al., 2003). Even in the highly politicized debates about 
Brazil’s use of GMOs, we see some promise in a guided discussion about the 
range of issues in the societal consideration of a new genetically engineered 
product.
National governments are often critical actors for facilitating socially 
acceptable choices (Stern and Fineberg, 1996). Fundamental to the concep­
tualization of a Brazilian PFOA is the understanding that it has to be embed­
ded in the regulatory systems in such a way that it reduces uncertainty for all 
members of society. At its best, it would serve as a forum for all stakeholders 
to understand the problem that needs to be addressed and the comparative 
impact of different options for solving the problem. In the Brazilian context, 
the PFOA would have to be organized by government authorities, but provide 
a forum that is viewed as legitimate by the multiple stakeholders. 
Representatives of these diverse stakeholders would have to have a voice and 
believe they had some influence in the assessment of options. This argument 
for transparency, equity, legitimacy and a data-driven process is well support­
ed in the literature (Susskind et al., 2000; Hemmati, 2002).
Many countries are considering modifications of policies and regulation 
for transgenic organisms (Munson, 1993; Miller, 1994; Hallerman and 
Kapuscinski, 1995; Sagar et al., 2000; Burachik and Traynor, 2002; NRC, 
2002; UNEP-GEF, 2003a,b). Because Brazil already has a complex system of 
laws and regulations, the authors suggest the following broad guidelines.
Finding #6: The PFOA should be organized by government authorities 
and discussed by a multi-stakeholder group.
Finding #7: In Brazil, the PFOA should be embedded in the policy and 
regulatory process.
Finding #8: In Brazil, PFOA staging can involve two meetings.
One option for incorporating the PFOA in the existing system would be 
to associate it with the CTNBio, but some modifications will be necessary 
(Figs 3.1 and 3.2). In 2003, the members of CTNBio were predominantly 
biotechnical scientists. In the future, this membership should be broadened







Fig. 3.1. Suggestions for embedding the problem formulation and option assess­
ment (PFOA) in the Brazilian regulatory system. Three ministries (Environment, 
Agriculture and Health) and the National Technical Biosafety Commission (CTNBio, 
Science and Technology Ministry) play a role in the final decision for environmental 
release of a genetically modified organism (GMO).
Stage 1. Based on GMO proposal, the first PFOA meeting is facilitated by 
government authorities and carried out by a multi-stakeholder group.
Stage 2. CTNBio receives the registrant’s proposal and the PFOA report. For a 
review of this report a composition of the CTNBio should be broadened in scientific 
expertise and stakeholders.
Stage 3. If the decision is favourable, it is sent to the ministries of Environment, 
Health, and Agriculture.
Stage 4. The proponent asks for respective licences from the ministries for 
laboratory, small- and large-field trials.
Stage 5. PFOA second meeting called to review the assessment in light of new 
results from testing.
Stage 6. The appropriate ministries review the PFOA report, promote 
public comment period, and may ultimately authorize for 
commercial use.
in scientific expertise in order to have the capacity to evaluate the results 
from a PFOA report that includes economic, social and environmental rec­
ommendations.
The CTNBio would receive the registrant’s proposal of a transgenic organ­
ism; this may come from a private company or federal research institute such as 
Embrapa. CTNBio would decide if there is sufficient consideration for biosafety 
in the proposal to consider it for use in Brazil. If the proposal has been accept­
ed for consideration, the CTNBio would convene the PFOA multi-stakeholder 
group for a first meeting to consider problem formulation (steps 1-2), and an 
initial review of options assessment including information needed for a full con­
sideration of steps 6-8. The CTNBio would receive the registrant’s proposal 
and the PFOA preliminary report and decide on whether to continue environ­
mental risk assessment. If the decision is favourable, it is sent to the ministries of 
Environment, Health and Agriculture. The proponent asks for respective
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licences from the ministries for laboratory as well as small- and large-scale field 
trials. Near the end of field trials, the second PFOA meeting is called to review 
the assessment in light of new results from testing. The report will define the 
problem and its scope and compare the options. It will represent the degree of 
consensus among the stakeholders on important issues as well as the range of 
opinions expressed. Finally, the appropriate ministries review the PFOA report, 
conduct a public hearings session, and decide if the GMO should be authorized 
for commercial use. In all cases, the PFOA meetings would be guided by a pre­
determined process, but sufficient flexibility needs to be allowed to respond to 
the unique characteristics of each case.
The staging of the PFOA process is particularly important because it must 
be designed to provide guidance for other sections of the environmental risk 
assessment, but at the same time the PFOA process needs to be informed by sci­
entific results from the studies conducted by other sections (Figs 3.1 and 3.2). 
The first PFOA meeting could be held prior to risk-assessment studies to help 
understand the problem, provide a preliminary review of options and highlight 
critical societal concerns. Then studies can be conducted during the following 
stages in the development of a transgenic plant (Andow et al., Chapter 1, this 
volume): (i) the design of transformation; (ii) focusing on set of events; (iii) 
characterization (laboratory and greenhouse); (iv) small-scale planned field 
trial; and (v) precommercialization. The second PFOA meeting should be con­
ducted when laboratory and field environment biosafety test results can be 
included in the process.
The societal discussion about critical issues, specifically GMOs, is best 
served if it is driven by scientifically guided assessment and review (CBD, 1992; 
Gibbons, 1999; NRC, 2002), as well as consideration of the social, economic 
and ethical concerns. This is also true for any PFOA process. Brazilian work­
shop participants emphasized that existing data and studies required by the 
environmental risk assessment would be necessary for a scientifically guided 
review. This also complies with the Cartagena Protocol on Biosafety.
Brazil has the scientific capacity to support a PFOA process and, if funds 
are allocated, the resources to conduct the multi-stakeholder dialogue. As the 
process is developed, there will always be a tension between efficiency in 
costs and time versus adequate coverage in representation and the extensive­
ness of the deliberation. There will be start-up costs in developing the process 
and organizing adequate reporting systems for information. In Brazil, many 
agency staff and stakeholder representatives will require capacity-building 
assistance to facilitate or participate in a PFOA. Though Brazil may have the 
resources to contemplate a more elaborate process, other countries may need 
to develop more streamlined processes that still encourage discussion.
Finding #9: A database of existing studies should be organized and 
integrated to support PFOA discussion as needed.
Brazil has a wide variety of information sources to support steps 1-8 of 
the PFOA, but data about existing technologies in the agricultural sector are 
frequently spread among several institutions. This information would be very 
useful for questions about production problems and related issues, however, 
it is often hard to find or difficult to interpret. In other cases, the required
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Fig. 3.2. Schematic workflow for the problem formulation and option assessment 
(PFOA) process. The regulatory body still needs to be defined by Brazilian authori­
ties. (* indicates involvement of the recognized authority within the country. This 
authority receives the PFOA document and decides how to proceed.)
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information is not available and it would be necessary to conduct additional 
surveys. Overall, for efficient problem formulation (steps 1 and 2) it would be 
necessary to establish a database where the information from several sources 
(census statistics, existing studies including economic, social, etc., papers and 
surveys) can be organized and integrated in a way that every person can 
understand it. When no studies exist, an inclusive research agenda should be 
developed to fill critical gaps using available resources, working to enhance 
the multi-disciplinary nature of data over time.
First, an inventory of all existing data sources will be required, such as the 
agricultural census, statistical yearbook, scientific database and botanical 
review. For example, the 1996 agricultural census produced by the Brazilian 
Institute for Geography and Statistics (IBGE) identified 93,688 rural establish­
ments involved in cotton cropping in Brazil. In recent years, there has been a 
significant change in the location of the cultivated area in Brazil, with a shift 
from the North-east and Meridian regions to the Midwest and the western 
part of Bahia (Fontes et al., Chapter 2, this volume). These changes had 
implications for the technological matrix and producer profiles, from the limit­
ed capital-intensive approaches of small farmers to the higher technological 
level of commercial farmers. Therefore, updated information is important for 
a PFOA analysis of Bt cotton.
In general, a literature review and new research efforts will be necessary 
at a regional level to provide information and analysis for consideration in 
steps 6-8. These studies will have to be conducted by a reliable scientific insti­
tution. A general producers’ survey is recommended to identify needs prioriti­
zation and projections of demand. For Brazilian cotton, a recent survey in the 
Midwest and part of the North-east (west of Bahia state) will supply some data 
relevant for a problem formulation.
Some data can be obtained from the literature about contained environ­
ment research on GMOs. In addition, new research approaches and field data 
at the regional level have to be assessed to determine the barriers to use, envi­
ronmental impacts (see Chapters 6 to 12, this volume), marketing issues and 
human health aspects of the GMOs, to name a few areas. For Brazilian Bt 
cotton, information about efficacy and cost are available from private compa­
nies, but these data will need to be reviewed by scientists in public institutions 
(Grossi et al., Chapter 4, this volume). In the short term, published findings 
from abroad have to be assessed.
In the case of Bt cotton, gene flow is of particular concern for Brazil 
because there are three native cotton species in which cross hybridization and 
hybrid formation with cultivated varieties has already been documented. 
Further scientific studies will be necessary to evaluate introgression and genet­
ic contamination effects (Johnston et al., Chapter 11, this volume). In addi­
tion, Brazil hosts a rich biodiversity with more than a million insect species.
Finding #10: PFOA serves as a good foundation for future monitoring 
of environmental and societal impacts of the technology.
Once a particular option has been accepted by the decision makers, its 
implementation and impacts will have to be monitored to identify possible 
shifts in the environment and society. The participants recommended that the 
nation develop systems for monitoring new technologies, and consider the
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PFOA model as an approach that can be adapted to postrelease monitoring 
as well as prerelease evaluation.
Next steps in the design of a Brazilian PFOA
In the 3-day workshop session the authors were introduced to the idea of a 
PFOA in environmental risk assessment, considered the types of questions 
and characteristics of the process, and made consensus recommendations 
about the value of a PFOA. The next step for a Brazilian team is to design 
the PFOA process based on a broader period of consultation and then imple­
ment the PFOA within environmental risk assessment. Brazil needs to devel­
op its own PFOA process. There are many documented experiences of 
multi-stakeholder processes that can serve as a resource bank, as well as 
numerous techniques to facilitate discussion and option assessment 
(Crowfoot and Wondolleck, 1990; Susskind et a/., 1999; to name a few). 
More details about how multi-stakeholder dialogues have been applied in the 
consensus-building process in other countries would help the designers’ 
understanding of how the PFOA might be applied. As a foundation, it would 
be very helpful to have a handbook that synthesizes this literature in light of 
the PFOA process for environmental risk assessment of GMOs. Many of the 
tools are publicly accessible on websites and through publications, but they 
are dispersed across organizations, agencies, countries and continents. A 
training handbook could guide the Brazilian design team through the major 
design issues and link them to ways others have addressed these issues. It 
would also serve as a reference as other countries develop their own PFOA 
for environmental risk assessment, or as a support tool for training regulators 
and stakeholders in the process. Overall, PFOA may be one component of a 
broader public-participation strategy for biosafety issues.
There are several critical issues that will need to be addressed while 
designing the Brazilian PFOA process. The keys to building a credible con­
sensus on a science-intensive policy question are: (i) perceptions about the 
fairness of the method used to select stakeholder representatives who are 
invited to participate in a multi-stakeholder dialogue; (ii) the management (by 
a professional ‘neutral’) of the complex give and take involved in such a 
process; and (iii) the preparation of a written report - embodying the discus­
sion and degree of consensus that will inform decision makers. The following 
represents a few issues and questions that will need to be considered, but this 
list is by no means exhaustive.
Independence and  leg itim acy
In the case of GMOs, PFOA is a needed tool for orienting scientific analysis of 
risks, and for addressing the conflict of questions of interest related to the subject. 
As with any other method, however, it can be manipulated depending on how 
different tendencies and expertise are represented. As stated in the findings sec­
tion, a government authority, possibly CTNBio, should convene the PFOA, but 
there are still many decisions to be made about how to identify and invite stake­
holders. The goal should be to balance the interests of all relevant stakeholders
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with the need to generate a credible analysis of the parties involved (Crowfoot 
and Wondolleck, 1990). Also, its results and reports can be used to inform and 
help decision makers to make decisions based on scientific analysis of the envi­
ronmental, social, ethical and economic risks posed by GMOs, or they may just 
be used to legitimate a priori decisions enforced by the lobby or pressure groups. 
It all depends on how independent and public the process will be.
One of the principal requirements for public legitimacy of the proposed 
PFOA process is independence. As pointed out in previous sections, if the 
host regulatory agency and the decision-making body are dominated by pro­
biotech representatives or anti-biotech representatives, it could become one 
more tool for legitimating biased decisions. Designers of the process will have 
to carefully address:
• how to guarantee independence
• how to guarantee that conflicting interests will be represented
• how to use techniques for identifying relevant stakeholders
• how to assure legitimacy of selected representatives
• how to finance PFOA in environmental risk assessment
• how to prepare participants with information
Eva luating s takeho lder contributions and  com paring  options  
PFOA designers will have to consider how diverse stakeholder contributions 
can be made in an open discussion without judgement, but at the same time 
use agreed upon criteria for managing information, scientific findings and 
diverse values. For example:
• how to identify a neutral party to facilitate the process
• how to establish ground rules to govern the dialogue
• how to pay attention to disparities in power and the ability 
stakeholders to participate fully
• how to enforce that trustful risk-assessment analysis will be 
when, and where necessary, and for the time it is necessary
• how to guarantee the transparency of the deliberation
• how to manage information so it is timely and accessable
• how to deal with a lack of consensus between experts
• how to guarantee that information produced will be released to
• how to assess the effectiveness of the participatory process
Linking recom m endations to decis ion m aking  
Finally, a written report about the PFOA deliberation will have to represent 
the critical issues, the degree of consensus and the range of opinions. Special 
attention will need to be paid to:
• how to present recommendations if there is no consensus
• how to take the results of the deliberation into the decision-making process 
in a timely manner
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C on clus ion
The rapid advances in modern biotechnology, particularly genetically engi­
neered products, will shape the coming decades of economic development. 
As more transgenic products are field tested and eventually approved for 
commercialization, scientists will also learn more about how to manage the 
possibility that something negative might happen, the risks and the socio-eco- 
nomic implications. In addition, a new array of possibilities is emerging from 
data obtained from functional genomics, and its potential impact on the sus­
tainability of agricultural production could be enormous. As more developing 
countries begin to evaluate the local applications of the technology, each 
country will have to develop its own approach for societal discussion. Some 
members of society may begin to accept GM varieties as simply obtained by a 
different biological process, while others may take principled positions against 
technologies that have the potential for irreversible harm to the environment. 
Still others may use a holistic approach for the safe use of genetically engi­
neered products, taking into account social, economic and ethical values.
For the last 15 years in Brazil, a range of other issues have been associ­
ated with the use of some biotechnology, mainly transgenic organisms and 
human and animal cloning, in such a way that political, economic, social, sci­
entific and ethical issues are part of discussions throughout the country. 
Questions exist due to the lack of scientific, social, economic and environ­
mental impact studies. Citizens also wonder about intellectual property rights, 
the build-up of gigantic transnational companies with focused influence 
around the world, and unresolved ethical, economic and social issues.
The coming years will be a challenging period for developing countries as 
they address issues such as the need for better training of scientists (including 
in the areas of risk assessment and monitoring of GM experiments) and in- 
house investments needed to continue the development of their capacity in 
the area of biosafety.
A societal multi-stakeholder discussion such as PFOA can strengthen the 
consideration of critical problems, the options we have for addressing them, 
and the role biotechnology and biosafety will play. We hope the coming years 
will give scientists greater confidence in developing appropriate methods to 
predict, or at least properly assess, the possible negative environmental 
impacts on a case-by-case basis and that a science-based discussion will 
inform public choices and allow these choices to be considered within the 
decision-making process.
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